News | Peripheral Artery Disease (PAD) | September 13, 2017

Philips Showcases Integrated Vascular Solutions at VIVA 2017

Company will highlight patient-centric interventional peripheral vascular solutions for diagnosis, image-guided therapy and connected care

Philips Showcases Integrated Vascular Solutions at VIVA 2017

September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from Sept. 11 – 14, 2017, applying advanced technologies and deep clinical insights to address peripheral vascular needs. With the addition of its recent acquisition, Spectranetics, Philips will for the first time highlight its expanded portfolio of interventional X-ray systems, advanced catheters for measurement and therapy, clinical informatics and services, including its Philips Azurion image-guided therapy platform, intravascular ultrasound (IVUS), Phoenix atherectomy system and Spectranetics' Stellarex drug-coated balloon.

More than 8 million people in the U.S. alone are affected by peripheral arterial disease (PAD) [1]. Many people do not experience symptoms and are not aware of even having the disease. In addition to having limited blood flow to the leg, patients are at increased risk for heart attack or stroke. Fortunately, PAD can be accessed and addressed through innovative solutions using minimally invasive procedures like atherectomy and cardiac imaging technology that may offer more accurate and reliable treatment options that can reduce recovery time for patients.

On Wednesday, Sept. 13, as part of the VIVA 17 Late-Breaking Clinical Trials program, Marianne Brodmann M.D., of the Medical University of Graz in Austria will present two-year data from the ILLUMENATE European randomized clinical trial (EU RCT) that evaluates how Spectranetics' Stellarex drug-coated balloon restores and maintains blood flow to arteries in patients with PAD. Stellarex received U.S. Food and Drug Administration (FDA) approval in July 2017. The ILLUMENATE EU RCT analyzes patency in the segment of diseased artery treated with Stellarex in over 300 patients from a challenging patient population.

The combination of Spectranetics' product range and Philips' portfolio of interventional imaging systems, devices, software and services offer innovative solutions for peripheral vascular therapy, according to the company. At this year's VIVA conference, Philips and Spectranetics will showcase technology including:

  • Stellarex, the only commercially available drug-coated balloon with two reported randomized controlled trials. It has demonstrated durability with consistently high patency rates in a wide range of patients, according to Philips;
  • Azurion is an image-guided therapy platform that enables clinicians to easily and confidently perform a range of routine and complex procedures, helping them to optimize interventional lab performance;
  • The Pioneer Plus catheter, a re-entry device with intravascular ultrasound (IVUS), a catheter-based imaging technology that allows physicians to visualize diseased vessels from inside the artery, to facilitate identification of true lumen location;
  • The Phoenix atherectomy system, which combines the benefits of existing atherectomy systems and delivers a hybrid [2] atherectomy option to help physicians tailor the treatment approach for each patient; and
  • SymphonySuite is Philips' comprehensive program that includes a robust set of tools to support efforts in opening, growing and maintaining office-based lab solutions.

For more information: www.usa.philips.com/healthcare

 

References

1. National Institutes of Health, Facts About Peripheral Arterial Disease (P.A.D.), NHLBI.NIH.gov, September 2017 
2. Directional cutting ability only available with Phoenix 2.4mm deflecting catheter

Related Content

Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program
News | Angiography | September 21, 2018
Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys campaign. The campaign aims...
How to reduce radiation exposure in the cath lab fluoroscopy. Imaging system in photo is a Philips XperFlex.
Feature | Angiography | June 06, 2018 | Dave Fornell, Editor
June 6, 2018 — Here is a checklist of dose-sparing practices for angiographic X-ray imaging used in the cath lab.
Philips Azurion angiography system, image-guided therapy system.

The Philips Azurion angiography system offers several imaging and software enhancements to aid guidance during complex interventional procedures.

Feature | Angiography | February 07, 2018 | Dave Fornell
Five new angiography systems were launched in 2017 that included improvements to speed workflow and improve both imag
Philips Azurion Platform Improves Clinical Workflow and Staff Experience Benefits
News | Angiography | December 04, 2017
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical...
Videos | Angiography | November 22, 2017
Shimadzu demonstrated its Trinias Interventional X-ray System at the 2017 Transcatheter Cardiovascular Therapeutics (
Philips Azurion Image-Guided Therapy Platform Improves Clinical Workflow for Interventional Procedures
News | Angiography | November 15, 2017
Philips announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography | September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Siemens Healthineers Announces First U.S. Install of Artis Pheno Angiography System
News | Angiography | July 05, 2017
Michigan Medicine recently became the first healthcare institution in the United States to install the Artis pheno, the...
Sponsored Content | Videos | Angiography | June 22, 2017
Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of
Sponsored Content | Videos | Angiography | May 03, 2017
Tom Kloetzly, sales and marketing VP for Shimadzu Medical Systems USA, explains the evolution of Shimadzu Corporation...
Overlay Init